Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday

MT newswireMT newswire2026/10/14 13:23
09:23 AM EDT, 10/14/2026 (MT Newswires) -- Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) advancing by 0.5%. Verastem (VSTM) shares were up more than 7% after the company said early data from its trial of VS-7375, a drug targeting KRAS G12D mutations, showed a 50% confirmed response rate in second-line pancreatic cancer and 43% in later-line lung cancer. Eton Pharmaceuticals (ETON) stock was up more than 1% after the company said it has signed an exclusive US licensing and supply agreement with Aquestive Therapeutics (AQST) for Aquestive's Libervant buccal film, a treatment for seizure clusters in patients with epilepsy. Alvotech (ALVO) shares were up more than 1% after the company and Advanz Pharma submitted a regulatory application for AVT29, a proposed biosimilar to Eylea 8 mg, in Europe.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny